Le Lézard
Classified in: Health, Science and technology
Subject: PDT

Regulatory Documentation: Navigating the Complexities of Documentation Compliance, Upcoming Webinar Hosted by Xtalks


In this free webinar, learn how to tackle the complex regulatory requirements for medical and in vitro diagnostic device manufacturing. Gain insights into componentized XML-based structured content authoring compared to an MS Word-based way of working. The featured speakers will discuss how to maintain consistency and compliance across regulatory data and content with accelerated documentation creation and review.

TORONTO, May 30, 2024 /PRNewswire-PRWeb/ -- Regulatory documentation for medical and in vitro diagnostic device manufacturers has become increasingly complex, specifically with the European Database on Medical Devices (EUDAMED). Incomplete submissions and lack of cohesive structure of technical documentation are the most common reasons for market approval delays, according to notified bodies.

Incomplete submissions and lack of cohesive structure of technical documentation are the most common reasons for market approval delays, according to notified bodies.

This webinar will explore how a data-driven and componentized approach to content management ensures consistency across data and content, accelerates documentation creation and review and assures compliance of documentation submissions in relation to device registration.

Attendees will learn techniques that will help them work more closely with product data to make content creation and delivery more compliant and accurate and make content an ever more valuable asset for its users.

Register for this webinar today to gain insights into the regulatory documentation requirements for medical and in vitro diagnostic device manufacturers.

Join experts from RWS, André Schlotz, VP Global Solutions; and Jörg Schmidt, Senior Solutions Architect, for the live webinar on Thursday, June 13, 2024, at 10am EDT (3pm BST/UK).

For more information, or to register for this event, visit Regulatory Documentation: Navigating the Complexities of Documentation Compliance.

ABOUT XTALKS

Xtalks, powered by Honeycomb Worldwide Inc., is a leading provider of educational webinars and digital content to the global life science, food, healthcare and medical device communities. Every year, thousands of industry practitioners (from pharmaceutical, biotechnology, food, healthcare and medical device companies, private & academic research institutions, healthcare centers, etc.) turn to Xtalks for access to quality content. Xtalks helps professionals stay current with industry developments, regulations and jobs. Xtalks webinars also provide perspectives on key issues from top industry thought leaders and service providers.

To learn more about Xtalks visit https://xtalks.com
For information about hosting a webinar visit https://xtalks.com/why-host-a-webinar/

Media Contact

Soumya Shashikumar, Xtalks, +1 (416) 977-6555 x371, [email protected], https://xtalks.com

SOURCE Xtalks


These press releases may also interest you

at 00:00
XSOOH has always been at the forefront of hair care innovation, striving to deliver cutting-edge  products  that enhance the way customers achieve their desired looks. In a world where time is precious, XSOOH  proudly announces the launch of the...

3 jui 2024
In a landmark event signaling its ambitious foray into the biopharmaceutical sector, LOTTE BIOLOGICS, under the leadership of CEO Richard W. Lee, held a groundbreaking ceremony for its inaugural plant at the Songdo Bio Campus in Incheon International...

3 jui 2024
On June 29, the "Gather Great Wisdom to Shape the Future of Intelligent Manufacturing?Special Exhibition on Design Intelligence and High Quality Development", hosted by the China Academy of Art (CAA), opened at the National Museum of China in...

3 jui 2024
Intermap Technologies ("Intermap" or the "Company"), a global leader in 3D geospatial products and intelligence solutions, announces a new financing. The Company is offering up to a maximum of 4,300,000 Class "A" common shares of the Company...

3 jui 2024
"The Classic Quotes by Xi Jinping," a multilingual TV show produced by China Media Group, aired in Kazakhstan on Tuesday after Chinese...

3 jui 2024
Ascentage Pharma (6855.HK), a global biopharmaceutical company engaged in discovering, developing and commercializing both first-in-class and best-in-class therapies for hematological malignancies, announced today that on July 2, 2024, in relation to...



News published on and distributed by: